ECRIN - European Clinical Research Infrastructure Network

Funding Calls

This list of calls for funding for COVID19 is curated by ECRIN and updated on a weekly basis. Calls featured in this list focus on research opportunities for European investigators, mainly in the field of clinical research, or areas underpinning clinical research. Last update on 28-06-2020.

 

COUNTRY FUNDING BODY TYPE OF STUDIES AMOUNT AVAILABLE DEADLINE

Austria
Austrian Science Fund Prevention, mitigation, detection, containment of epidemics, including SARS CoV2 and impact of current epidemic Not specified 30-09-2020

Czech Republic
Grant Agency of the Czech Republic, collaboration with Austrian Science Fund – International projects As stipulated in the FWF call above, International projects must also focus on: Prevention, mitigation, detection, containment of epidemics, including SARS CoV2 and impact of current epidemic. Not Specified 30-09-2020

Czech Republic
Czech Technology Agency Innovative solutions for combating the current epidemic and improving preparedness in future outbreaks 40 M CZK per project 31-12-2020

France
National Research Agency (ANR) – “RA-COVID19” Operational/interventional studies for prevention or diagnostics, clinical trials, vaccine trials, Epidemiology and surveillance, OneHealth approaches, socio-economic impact studies Epidemiology, Physiopathogenesis, Infection prevention and control, Ethics and social dynamics, Global issues of the Covid-19 epidemic. 28-10-2020

France
BPI France/ Secretariat Général Pour L’Investissement Public private partnerships for developing and producing therapeutic solutions for COVID19, including clinical trials 4M to 50 M € per project 30-09-2020

Germany
German Research Foundation Prevention, early detection, containment and investigation of the causes, impacts and management of epidemics and pandemics including but not exclusively SARS CoV 2 Not specified Letter of intent: 01-07-2020 / Final submission: 01-09-2020

Germany
Federal Ministry of Education and Research Vaccine development and clinical trials NA 31-12-2020

Ireland
Science Foundation of Ireland/ Enterprise Ireland and IDA Ireland Innovative solutions for contact tracing, frontline care, diagnostics, epidemiological tools, monitoring of control measures, mitigation of crisis on a sanitary, social and economic level, and more Funding requests will depend on the specific needs of the project. 24-08-2020

Italy
Area Science Park and ARGO System Medical-health fields, artificial intelligence algorithms and scientific data extraction – using the ORFEO data Center 400K € total 31-07-2020

Malta
Malta Council for Science and Technology & Malta Enterprise Epidemiology, Basic Science, Clinical Research, Social Sciences, IT, 5,3 M € total 30-12-2020

Norway
Norwegian Cancer Society Incidence/prevalence, consequences and treatment of cancer patients with COVID19 in Nordic countries 200K €/project 01-09-2020

Spain
Banco Santander/Crue Universidades Espanolas Big data analysis, clinical research, basic science, socio-economic impact, innovative products and solutions for crisis mitigation 8,5 M € Total Rolling applications until 18 December 2020

Sweden
Swedish Research Council Exceptional redirection of ongoing grants to focus on COVID19 No more than 1/3 of amount yearly allocate Ongoing – requires an authorization

Sweden
Vinnova Innovation projects in the health field that dampen the prevalence and effects of the covid-19 pandemic SEK 5 million/project 18-08-2020

Switzerland
ETH Zurich Research in all research fields, in collaboration with Asian nations, for the fight against the COVID19 epidemic. 25 kCHF per project 30-08-2020

United Kingdom
British Heart Foundation Clinical research on cardiovascular disease and COVID19 Not specified – applications must align with UK COVID19 priorisation process Rolling applications evaluated weekly

United Kingdom
GOSH / Sparks foundation COVID19 and rare diseases in children 250K £/project 19-08-2020

United Kingdom
UK MRC Virology, Immunity and Pathophysiology, Diagnostics, Epidemiology, PPE and other protective material, Public Health, Clinical Research, Vaccines, Health Care and Delivery Variable depending on project needs Rolling call - 1 Apr 2021

United Kingdom
NIHR Urgent Public Health Research – through National Priorisation Process NA Rolling applications

United Kingdom
NIHR Solutions for low and middle-income countries – clinical trials, epidemiology, prevention, diagnostics and more 1M£/project 10-08-2020/28-09-2020

United Kingdom
UK Research and Innovation/ Newton Fund Innovative solutions to gather critical data, support manufacture or wide scale adoption of an intervention, better understand and mitigate impact of the epidemic in Low and Middle Income countries 80% of the full economic cost none - apply at any time

United Kingdom
UK Research and Innovation Innovative solutions to gather critical data, support manufacture or wide scale adoption of an intervention, better understand and mitigate impact of the epidemic 80% of the full economic cost none - apply at any time

Pan European
Partnership for Advanced Computing in Europe (PRACE) Projects requesting computer resources for: epidemiology, bioinformatics, bio-simulation, biomolecular analysis, other studies to mitigate the epidemic Resources requested reviewed for each proposal Open until further notice

Pan European
EDCTP Training and capacity building opportunities on epidemiology to fight epidemics in Africa, in support of the African CDC – COVID19 focus is highly recommended 50 K €/ student 30-07-2020

Pan European
Interreg- Northern Periphery and Arctic Program Clinical aspects of COVID19, health and wellbeing of populations during and after the pandemic, technological solutions, citizen engagement, economic impact, and more 45K € per project 30-09-2020

Pan European
TRANSVAC Support vaccine-related projects currently in the preclinical phase of development NA 04-08-2020

International
GILEAD Solutions for long term care, real world safety and effectiveness of remdesivir, viral kinetics, care of high-risk patients, and more 250K USD/project – although exceptions can exist 03-08-2020

International
CEPI Accelerating vaccine development and manufacturing Phase II - vaccines striving for licensure/emergency authorization in 12-18 months or less and, to ensure the availability of sufficient doses by 2021 NA 28-09-2020

 


Legal disclaimer for the COVID-19 Taksforce internet pages.